Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

49.90
-0.0900-0.18%
Post-market: 49.50-0.4000-0.80%19:58 EDT
Volume:1.67M
Turnover:82.80M
Market Cap:6.18B
PE:-14.77
High:50.55
Open:50.20
Low:48.70
Close:49.99
Loading ...

Barclays Remains a Buy on Guardant Health (GH)

TIPRANKS
·
Yesterday

Director Tariq Musa Reports Disposal of Common Shares in Guardant Health Inc

Reuters
·
21 Jun

Director Myrtle S. Potter Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
21 Jun

Guardant Health Inc. Concluded Annual Stockholders Meeting

Reuters
·
21 Jun

GH Research Submits Complete Response to FDA for Depression Treatment GH001; Shares Rise

MT Newswires Live
·
21 Jun

GH Research submits complete IND hold response to FDA

TIPRANKS
·
21 Jun

Director Meghan V. Joyce Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
17 Jun

Co-CEO AmirAli Talasaz Reports Disposal of Common Shares in Guardant Health Inc

Reuters
·
10 Jun

Guardant Health Announces Promising Results from LIBERATE Study, Showcasing Guardant Reveal's Accuracy in Detecting Minimal Residual Disease in Early-Stage Breast Cancer

Reuters
·
09 Jun

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Zai Lab (ZLAB) and Guardant Health (GH)

TIPRANKS
·
06 Jun

Guardant Health Inc.'s CIO, Kumud Kalia, Reports Disposal of Common Shares

Reuters
·
06 Jun

Cathie Wood’s ARK Investment buys 99.6K shares of Guardant Health today

TIPRANKS
·
05 Jun

Director Meghan V. Joyce Reports Disposal of Guardant Health Inc. Common Shares

Reuters
·
04 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Hewlett Packard Enterprise, Venture Global

Reuters
·
04 Jun

Leerink Partners Remains a Buy on Guardant Health (GH)

TIPRANKS
·
03 Jun

Guardant Health Shares up 1.2% After FDA Grants Breakthrough Device Tag to Co's Multi-Cancer Detection Test

THOMSON REUTERS
·
03 Jun

Guardant Health Shares up 2.1% Premarket After FDA Grants Breakthrough Device Tag to Co's Multi-Cancer Detection Test

THOMSON REUTERS
·
03 Jun

FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection Test

Reuters
·
03 Jun

FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (Mcd) Test

THOMSON REUTERS
·
03 Jun

Cathie Wood’s ARK Investment buys 158.7K shares of Guardant Health today

TIPRANKS
·
03 Jun